“Polypharmacy,” or the concurrent use of multiple medications, can lead to harmful drug interactions—which is especially dangerous for cancer patients about to undergo therapy, according to a study led by Wilmot Cancer Institute researchers.
The UNC Lineberger Patient-Reported Outcomes Center of Excellence recently held its inaugural retreat, which was the center’s official launch.
